Clinical evaluation of the NK3 receptor antagonist fezolinetant (a.k.a. ESN364) for the treatment of menopausal hot flashes. (September 2017) - Depypere, Herman; Timmerman, Dirk; Donders, Gilbert; Sieprath, Peter; Ramael, Steven; Combalbert, Jean; Hoveyda, Hamid R.; Fraser, Graeme L.